YUBO INTERNATIONAL BIOTECH LIMITED
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | — | $0 | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $58.0K | $149.0K | $63.0K | $58.0K | $55.0K | $60.0K | $47.0K | $80.0K |
| Operating Income | $-58.0K | $-149.0K | $-63.0K | $-58.0K | $-55.0K | $-60.0K | $-47.0K | $-80.0K |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | $86.0K | $75.0K | $67.0K | $58.0K | $51.0K | $43.0K | $37.0K | $30.0K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | $0 | — | — | — | — | — |
| Net Income | $-144.0K | $-224.0K | $-130.0K | $-116.0K | $-106.0K | $-103.0K | $-84.0K | $-110.0K |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 389.0M | 389.0M | 388.2M | 388.2M | 389.2M | 389.2M | 388.1M | — |
| Shares Outstanding (Diluted) | 389.0M | 389.0M | 388.2M | 388.2M | 389.2M | 389.2M | 388.1M | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |